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The feasibility of natural oriﬁce translumenal endoscopic surgery (NOTES) resection for rectal cancer has been demonstrated in
both survival swine and fresh human cadaveric models. In preparation for transitioning to human application, our group has
performed transanal NOTES rectal resection in a large series of human cadavers. This experience both solidiﬁed the feasibility
of resection and allowed optimization of technique prior to clinical application. Improvement in specimen length and operative
time was demonstrated with increased experience and newer platforms. This extensive laboratory experience has paved the way
for successful clinical translation resulting in an ongoing clinical trial. To date, based on published reports, 4 human subjects
have undergone successful hybrid transanal NOTES resection of rectal cancer. While promising, instrument limitations continue
to hinder a pure transanal approach. Careful patient selection and continued development of new endoscopic and ﬂexible-tip
instruments are imperative prior to pure NOTES clinical application.
1.Introduction
Just as laparoscopy resulted in a major paradigm shift in the
ﬁeld of gastrointestinal surgery, NOTES has the potential
to be equally as ground breaking and likely represents the
next step in the evolution of minimally invasive surgery [1].
Proposed advantages of NOTES include faster recovery time,
shorter hospital stays, improved pain control, and avoidance
of potential abdominal wall complications including wound
infection and hernia [2]. The range of operations under
investigation is rapidly increasing. Currently, transvaginal,
transgastric, transesophageal, and transanal approaches have
been described. The international and national experience
now counts several thousand cases of successfully performed
hybrid transvaginal NOTES procedures including but not
limited to cholecystectomy, nephrectomy, and vertical sleeve
gastrectomy [3–9]. Progress however, continues to be ham-
pered by instrument limitations as well as safety concerns
regarding NOTES translumenal access, particularly regard-
ing access closure.
Transanal access for colon resection has been proven
safe and feasible in both swine and fresh human cadaveric
models [10, 11]. The advantages of transanal access for
colorectal resection are multiple. First, the availability of
well-established platforms such as transanal endoscopic
microsurgery (TEM) to gain access to the peritoneal cavity
facilitates performance of endorectal and transrectal pro-
cedures [12]. Second, creation of the enterotomy though
the organ to be resected rather than an otherwise healthy
organ obviates concerns regarding safe, reproducible clo-
sure associated with other NOTES access points. In 2007,
Whiteford et al. described the ﬁrst transanal NOTES radical
sigmoidectomy in human cadavers [13]. Although colon
and mesenteric dissection could be technically achieved with
use of the TEM platform, diﬃculties were encountered
with mobilization of adequate specimen length secondary
to instrument inability to overcome anatomic constraints.
Whileinstrumentlimitationscontinuetobeabarriertopure
application of transanal NOTES resection, this approach has
since been optimized in both a swine and fresh human2 Minimally Invasive Surgery
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Figure 1: (a) Tranasanal extraction of specimen following completely NOTES in a swine survival model. (b) Intact stapled coloanal
anastomosis following specimen transection.
cadaveric model. Based on this work, human clinical trials
are currently underway worldwide [14–16].
The aim of this paper is to provide a review of our
experiencewithtransanalNOTEScolorectalresectionaswell
as an update on the current status of human clinical trials
worldwide.
2. TechniqueDevelopment
To determine the feasibility of transanal NOTES rectosig-
moid resection, a pilot study using a nonsurvival porcine
model was performed [11]. Rectosigmoid resection using
the TEM platform was replicated in this model. A purse-
string suture was placed in the distal rectum to prevent fecal
outﬂow and contamination. Following this, full-thickness
incisionoftherectalwallwasperformed.Uponentryintothe
presacral space, en-bloc resection of the rectosigmoid colon
and its mesentery could be performed endoscopically. Once
the peritoneal reﬂection was reached, the peritoneal cavity
was entered and dissection of the sigmoid colon continued
proximally until anatomic and instrument limitations were
encountered. The colon was then pulled out through the
anus, transected and a stapled colorectal anastomosis per-
formed. Figures 1(a) and 1(b).
From this nonsurvival model, several key limitations
were identiﬁed and addressed. First, the sharp angle of
the sacral promontory and narrow swine pelvis hindered
proximal dissection. In an attempt to overcome these
anatomic limitations, a combined transgastric and transanal
approach was attempted. While prolonging operative time,
dualtransanalandtransgastricapproachimprovedvisualiza-
tion, retraction, and ultimately mobilization of the proximal
colon yielding additional specimen length. The addition of
transgastric endoscopic access resulted in an average gain
of 5.8cm in colon length [11]. Other anatomic constraints
included the ﬂaccid swine bladder which obscures the
rectosigmoid, spiral colon conﬁguration, and lack of a
true splenic ﬂexure making proximal colonic mobilization
more challenging. To overcome these anatomic challenges,
exposure was improved by positioning animals in the
Trendelenburg and right lateral decubitus position.
A second impediment centered on technical optimiza-
tion of the colorectal anastomosis. A stapled colorectal
anastomosis was performed in all animals in this series.
Following anastomotic inspection the staple line was noted
to be incomplete in 2 out of 9 (22%) animals. A small
posterior anastomotic defect was identiﬁed in each case
and believed to be secondary to an incomplete purse-string
suture on the open distal rectum. This discovery led to
technique modiﬁcation. A transanal purse string was placed
underdirectvisionusinganalretractors,ratherthanthrough
the proctoscope, with improved results [11].




of application. A two-week survival study using 20 swines
was initiated [10]. This study compared outcomes of pure
transanal endoscopic resection versus combined transanal
and transgastric rectosigmoid resection as described in the
pilot study. All procedures were performed successfully
without transabdominal assistance and all specimens were
grossly intact with respect to integrity of colonic wall and




using a colonoscope for visualization. (b) Set up for transanal NOTES rectosigmoid resection with laparoscopic assistance in cadavers. (c)
Transanal circumferential and full-thickness rectal dissection through the TEM platform, starting just below the purse-string suture, in a
female patient with an upper rectal cancer. (d) Transanal posterior mesorectal dissection using laparoscopic instruments through the TEM
platform in a female patient. (e) Transanal mobilization of the anterior rectal wall and peritoneal entry through the TEM platform in a
female patient. (f) Intact rectosigmoid specimen and mesorectum following transanal NOTES procedures.
demonstratedasigniﬁcantincreaseinthelengthofspecimen
able to be mobilized and resected. No mortalities occurred in
either group. Two morbidities, one intraabdominal abscess
and one abdominal wall hematoma, occurred in the dual
transgastric and transanal group identiﬁed at necropsy.
Experimental evidence from both the nonsurvival and
survival swine studies demonstrated both the feasibility and
safety of transanal NOTES rectosigmoid resection using
TEM with or without transgastric endoscopic assistance.
This work served as the foundation for transitioning to
human application.
2.1. Technique Optimization and Transitioning to Clinical
Application. In preparation for human application, fresh
human cadaveric models were utilized to optimize this
technique. The purpose of this model was to both determine
the technical and oncologic feasibility of this technique
and eventually optimize this procedure for human clinical
trials. Since initiation of this protocol, transanal NOTES
rectosigmoid resection has been successfully performed in
32 fresh human cadavers [17]. NOTES transanal endo-
scopicrectosigmoidresectionwasperformedusingtransanal
dissection alone (n = 19), with transgastric endoscopic
assistance (n = 5) or with laparoscopic assistance (n = 8). Of
t h e1 9c a d a v e r i co p e r a t i o n sp e r f o r m e dv i aap u r et r a n s a n a l
approach, 2 were performed using laparoscopic and TEO
instruments through the TEO platform, 8 using endoscopic
assistance with a gastroscope (Pentax) inserted through the
TEO platform, and 9 utilized endoscopic assistance through
a novel rigid endoscopic platform inserted through the TEO
platform (ISSA, Storz). The purpose of this novel platform
was to provide additional rigidity to the gastroscope.
2.2. Technique. As in swine, the rectum was occluded
transanally with a 2-0 vicryl purse-string suture approx-
imately 3-4cm from the anal verge, above the sphincter
complex. The 7.5cm TEO proctoscope (Storz, Tuttlingen,
Germany) was then inserted transanally and sealed with a
faceplate. Circumferential dissection of the rectum was ini-
tiated above the anal sphincter complex using electrocautery
and TEO dissecting instruments (Figure 2(c)). Low pressure
CO2 insuﬄation (9mmHg) was used to facilitate dissection
(Figures 2(a) and 2(b)). Posterior entry into the presacral
space was facilitated by CO2 insuﬄation and ﬂexible-tip
instruments. The mesorectum was mobilized sharply, with
or without electrocautery or a bipolar device (Autosonix
ultrashears, Covidien, Norwalk, CT), and mesorectal dis-
section proceeded cephalad along the avascular presacral
plane (Figure 2(d)). This plane of dissection was extended
medially, laterally, and anteriorly to achieve circumferential4 Minimally Invasive Surgery
rectal mobilization and TME. The shorter proctoscope was
replaced with the 15cm proctoscope to improve expo-
sure. The peritoneal reﬂection was visualized and divided
anteriorly after carefully mobilizing the vagina or prostate
from the anterior rectal wall, and the peritoneal cavity
was entered (Figure 2(e)) .T h ep e r i t o n e a la t t a c h m e n t so f
the rectosigmoid were divided using electrocautery and a
bipolar device (Autosonix). Proximal dissection was con-
tinued either via transanal endoscopic dissection alone or
with transgastric endoscopic or laparoscopic assistance. The
inferior mesenteric pedicle was taken in all cadavers using
a bipolar device or a linear endoscopic stapler (EndoGIA,
Covidien) inserted transanally through the TEO platform.
In cadavers undergoing sole transanal rectosigmoid
resection, dissection into the peritoneal cavity was extended
as cephalad as possible using TEO and laparoscopic instru-
ments,withorwithouttransanalendoscopicassistanceusing
a gastroscope (Pentax Medocal Incl, Montvale, NJ, USA).
When dissection could not be extended any further, the
proctoscopewasremoved,andthespecimenwasexteriorized
in preparation for specimen extraction.
Transgastric assistance, when utilized, was performed
as previously described [10]. In brief, following maximal
transanal rectosigmoid mobilization, peroral transgastric
peritoneal access was obtained using a 12.8mm colonoscope
(Pentax). A 4mm gastrostomy was then made using a needle
knife (Cook Medical Inc., Winsont-Salem, NC, USA) and
dilated. Once access was established, the colonoscope was
advanced into the peritoneal cavity. In 2 cases, transgastric
access and dissection were performed using a novel endo-
scopic platform (Anubiscope, Storz). The lateral peritoneal
attachments of the rectosigmoid, sigmoid, and descending
colon was then divided using the needle knife. Transanal and
transgastric mobilization were combined until no further
mobilization could be safely achieved. For operations per-
formed with laparoscopic assistance, 1–3 abdominal trocars
were inserted to improve visualization and/or facilitate colon
retraction. This permitted more proximal dissection of the
rectosigmoid junction.
Regardless of operative approach, once the rectosig-
moid specimen had been fully mobilized, it was exteri-
orized transanally, measured and subsequently transected
(Figure 2(f)). A Lone Star retractor (Cooper Surgical, Trum-
bull,CT,USA)wasthenpositionedandahandsewncoloanal
anastomosis performed between the proximal sigmoid colon
and distal anorectal cuﬀ as previously described.
2.3. Technical Feasibility and Optimization. In this series
of 32 fresh human cadavers, 21 were male and 11 female
with mean BMI of 24kg/m2. Mean operative time was
5.1 hours and mean specimen length 53cm (range 15
to 91.5cm). A signiﬁcant improvement in both specimen
length and operative time was demonstrated with increased
experience [17]. In addition, comparison by operative
approach demonstrated signiﬁcantly improved specimen
length with addition of laparoscopic assistance. Cases that
employed a hybrid transgastric and transanal approach
initially resulted in increased specimen length; however,
this became less pronounced with increasing experience
in transanal dissection alone. In 8 (25%) cadavers, an
enteric perforation was identiﬁed in the sigmoid (n = 2),
rectum (n = 3), or proximal colon (n = 2). Factors
associated with complication included obesity, poor cadaver
quality, pelvic adhesions, and a redundant sigmoid colon.
In addition, all enteric perforations occurred in cadavers
undergoing pure NOTES rectosigmoid resection during
attempted mobilization of the proximal descending colon.
Limitations in dissecting instruments, current platforms,
and proximal visualization are likely responsible for the
rate of enteric perforation. While the feasibility of pure
NOTES colorectal resection could be replicated in fresh
human male and female cadavers, the complication rate
highlights that clinical application is not yet possible and
a hybrid laparoscopic approach is essential. In addition to
serving as an experimental platform, this model also enabled
standardization of a hybrid laparoscopic procedure prior to
clinicaltrials.Itallowedforthecapabilityoftroubleshooting
and overcoming the procedural learning curve prior to
human application.
2.4. Oncologic Feasibility. Another question that needed to
be addressed prior to transitioning to human trials pertained
to the adequacy of oncologic resection. Both cadaveric
work done by our group as well as the one by Whiteford
et al. [13] illustrate that this operation is oncologically
appropriate. As total mesorectal excision (TME) remains the
gold standard in the treatment of rectal cancer, we evaluated
oncologic adequacy in our cadaveric model by specimen
assessment following procedure. In our series of 32 cadavers,
the mesorectum was intact in 100% of specimens following
TME. The capability of performing an adequate oncologic
operationwascorroboratedin2011byRiederetal.[18].This
paper randomized male cadavers to either laparoscopic or
transanal sigmoid resection for a lesion simulated at 25cm.
Lymph node yield as well as adequate resection margins
were evaluated. This study demonstrated similar lymph
node yield following transanal rectosigmoidectomy when
compared to the laparoscopic approach. Given the distance
of the simulated lesion however, laparoscopic assistance
was necessary in the transanal group to achieve adequate
proximal resection margin. Nonetheless, results from this
study support the feasibility of this technique as an adequate
oncologic procedure.
3.ClinicalTrials
Success in animal and cadaveric models has led to worldwide
human clinical trials [14–16]. In 2010, our group reported
the ﬁrst hybrid NOTES transanal total mesorectal excision
(TME) in a 76-year-old female with a T2N1 rectal cancer
treated preoperatively with neoadjuvant therapy [16]. Visu-
alization and assistance during the procedure were aided
with a transabdominal 5mm port that later became the
stoma site and 2mm needle ports of which one was used
as a drain site. The TME was performed entirely transanally
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with mobilization of the splenic ﬂexure and proximal intra-
abdominal colon performed laparoscopically. The specimen
was then transected transanally and a handsewn coloanal
anastomosis with diverting loop ileostomy was performed.
The operative time was 4 hours and 30 minutes. The
patient did well postoperatively and was discharged home
on postoperative day four. The ﬁnal pathology demonstrated
a ypT1N0 tumor with intact mesorectum that included
23 negative lymph nodes and negative proximal, distal
and radial margins. The patient later underwent ileostomy
reversal with good function and has remained free of disease.
Since this report, 3 additional cases have been reported
in the literature. Zorron et al. published a series of 2 patients
who underwent successful hybrid NOTES TME for rectal
cancer [14]. In this series, mesorectal dissection is described
with both an endoscope and with a transrectal rigid single
port device. The ﬁrst case was that of a 54-year-old male
who presented with an adenocarcinoma 8cm from the rectal
verge causing 90% stenosis of the lumen. Secondary to the
obstructing nature of his tumor, the patient did not undergo
neoadjuvant therapy. Hybrid transcolonic NOTES TME was
performed using a colonoscope. Following identiﬁcation of
the anal verge, a 2.5cm posterior incision was performed
in the planned line of rectal resection. The colonoscope
was then inserted directly into the perirectal retroperitoneal
space and dissection was performed by directing the endo-
scope via CO2 insuﬄation through a working channel.
Once dissection reached the level of the peritoneal cavity,
pneumoretroperitoneum was lost and dissection was then
facilitated by laparoscopic assistance via 3 transabdominal
trocars. Once dissection was complete, the specimen was
removed transanally and a stapled anastomosis and right
transverse diverting colostomy were performed. Operative
time was 350 minutes. Both the intra- and postoperative
courses were uncomplicated and the patient was discharged
home on postoperative day 6. Pathology revealed an intact
mesorectum with 3 out of 12 retrieved lymph nodes positive
for tumor (pT3N1). Margins were free of tumor.
The second patient reported in this series was a 73-year-
old female with a diagnosis of rectal adenocarcinoma 6cm
from the anal verge who underwent neoadjuvant therapy.
In contrast to the ﬁrst patient, this patient underwent a
hybrid NOTES TME using a transanally inserted rigid, single
port device. The single port access device has 3 channels
for instrumentation, with 2 additional channels for CO2
insuﬄation. Using a 10mm 45-degree laparoscopic camera,
in lieu of a ﬂexible colonoscope, the TME dissection was
then carried out transanally with laparoscopic assistance
as previously described. Operative time was 360 minutes.
This patient also recovered uneventfully and was discharged
home on postoperative day 6. Pathology revealed tumor-free
margins and intact mesorectum with 2 of 11 lymph nodes
positive for tumor (pT3N1).
The third case was reported by Tuech et al. in 2011 [15].
This report describes a 45-year-old woman with a reported
T1sm3 rectal adenocarcinoma 3cm above the dentate line.
For this procedure a single port access device, endorec trocar
(Aspide, France), was also used. This trocar consists of a
rigid port with 40mm outer diameter, three 5mm, and
one 10mm access channel and an air inlet tube through
which CO2 can be inﬂated. The extraperitoneal rectum was
completely mobilized using this device. Once the lateral
rectal attachments were divided, the rectovaginal peritoneal
reﬂection was identiﬁed and perforated to gain access to the
abdominal cavity. A second endorec trocar (Aspide, France)
was then placed through the proposed ileostomy site and
laparoscopic assistance with proximal colonic mobilization
ensued. The procedure was performed successfully without
complication. Operative time was 5 hours. The patient
did well postoperatively without complication. Pathology
revealed a pT1sm3N0 tumor. Fifteen lymph nodes were
retrieved with the specimen.
While the principles of NOTES transanal rectal cancer
resection remain the same, the methodology, particularly
with respect to transanal dissection, varies between clinical
trials. The consensus is that the majority of the rectal
and mesorectal dissection can be achieved transanally while
laparoscopic assistance is needed for proximal colon mobi-
lizationandtissueretraction.Itisthepreferenceofourgroup
at this time to use the rigid TEO platform for transanal
endoscopic rectal dissection rather than a ﬂexible single port
device. The TEO platform comes in 2 lengths, provides
rigid stabilization for instrument manipulation, and is an
established cost eﬀective, reusable platform readily available
at our institution. Nonetheless, the published reports thus
far demonstrate that adequate hybrid NOTES TME can be
achieved using ﬂexible or rigid platforms and highlight the
importanceofcontinuedworkanddevelopmentinthisﬁeld.
As part of our eﬀorttofurtherthiswork,wearecurrently
enrolling patients into an ongoing United States based Insti-
tutional Review Board (IRB) approved prospective clinical
trial [19]. Patients selected for this approach include those
with biopsy proven resectable adenocarcinoma of rectum
located 4–12cm from anal verge who are otherwise eligible
to undergo standard open or laparoscopic low anterior
resection with temporary diverting stoma. Tumors must
b ep r e o p e r a t i v e l ys t a g e da sn o d en e g a t i v e ,T 1( h i g hr i s k
features), T2 or T3 based on pelvic MRI with no evidence
of metastasis on staging CT scans. For preoperatively
staged T3N0 tumors, patients must have completed full-
course neoadjuvant treatment. Procedures are performed
following the same steps as described in cadavers, using
an abdominal and perineal team working simultaneously.
TransanaldissectionisperformedviatheTEMplatformwith
laparoscopic assistance through 1–4 abdominal trocars. The
right lower quadrant trocar is later used as the ileostomy site.
Following transanal specimen retrieval, a handsewn coloanal
anastomosis with diverting ileostomy is performed. For this
protocol, a diverting ileostomy is standard given perfor-
mance of a low-lying anastomosis in patients who likely will
require either neoadjuvant or adjuvant chemoradiation.
4. Conclusion
Transanal NOTES rectosigmoid resection is feasible and safe
as demonstrated in both a swine and fresh human cadaveric
model. Clinical application has been promising, with several6 Minimally Invasive Surgery
hybrid laparoscopic and transanal procedures for rectal
cancers published to date. While encouraging, instrument
limitations continue to hinder a pure transanal approach.
Continued development of new ﬂexible endoscopic plat-
forms and ﬂexible-tip instruments are imperative prior to
pure NOTES clinical application in humans. In addition, the
success of clinical application will ultimately rely on careful
patient selection and strict adherence to oncologic principles
of resection with all planned procedures done in the setting
of IRB-approved clinical trials.
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